Proximie

Proximie Competitive Intelligence & Landscape

proximie.com ·

Overview

Proximie Overview

Proximie is a healthcare technology company founded in 2016 and headquartered in London, UK. It specializes in developing a cloud-based operating system for intelligent operating rooms, which integrates with various medical devices and OR setups to enable real-time connectivity, data sharing, and analytics during surgical procedures (Exa). The company's core product is its platform that leverages augmented reality, artificial intelligence, and machine learning to allow surgeons to remotely guide and collaborate during surgeries, democratizing access to expert surgical knowledge and training (Equilar).

Proximie targets hospitals, healthcare providers, and medical device companies, aiming to improve patient safety, enhance surgical training, and accelerate device adoption, all while reducing costs and time in surgical procedures (Proximie). The company has raised approximately $118 million in funding, reflecting its growth and the increasing demand for innovative digital health solutions (Proximie). Its mission centers on transforming surgical care globally by integrating cutting-edge technology into operating rooms and expanding equitable access to quality surgical services worldwide (Global Health Initiative). With around 96 employees, Proximie continues to expand its influence in the healthtech industry, driven by its commitment to healthcare innovation and global health impact.

Proximie

Proximie Weekly Intel Updates

Receive weekly intel updates about Proximie straight to your inbox.

Competitors

Proximie Competitors

Proximie is a leading player in the surgical technology space, offering an operating system for intelligent operating rooms that connects people, data, and devices to enhance surgical outcomes through real-time AI-powered insights (Proximie). Its cloud-based platform focuses on increasing OR productivity, improving collaboration, and accelerating innovation, with notable clients like Johnson & Johnson and Medtronic, and an estimated annual revenue of $28.4 million (Growjo).

Augmedics is a prominent competitor, specializing in augmented reality surgical navigation systems, particularly for spine surgery. Its key differentiator is AR-guided visualization that allows surgeons to see 3D images overlaid on the patient's body, enhancing precision (BounceWatch). Compared to Proximie’s broader OR connectivity platform, Augmedics focuses more on AR-based navigation, and its market share is growing rapidly in specialized surgical fields.

Osso VR offers a virtual reality surgical training platform that emphasizes immersive simulation for medical professionals. Its competitive edge lies in providing realistic, repeatable training scenarios that improve surgical skills without risks to patients (BounceWatch). While Proximie targets real-time surgical collaboration and data integration, Osso VR primarily enhances surgical education and training, positioning it as an indirect but significant competitor in surgical innovation.

Fundamental Surgery develops robotic surgical systems that aim to improve minimally invasive procedures. Its key differentiator is integrating robotics with advanced visualization and AI to increase surgical precision and outcomes (BounceWatch). Compared to Proximie’s cloud-based platform, Fundamental Surgery’s focus on robotic systems makes it more hardware-centric, with a strong presence in robotic-assisted surgeries and a growing market share in that niche.

NHS Transformation Unit and similar public health entities are indirect competitors, focusing on healthcare system efficiency and digital transformation, which can include surgical tech solutions. While they do not compete directly in product features, their market influence and adoption of digital health innovations impact the competitive landscape for companies like Proximie (BounceWatch).

Product & Pricing

Proximie Product and Pricing Intelligence

Proximie offers a cloud-based surgical collaboration platform that enhances operating room efficiency, training, and patient safety through real-time video and data sharing (Proximie Ltd - Digital Marketplace). The platform is certified for cybersecurity and compliance with GDPR and HIPAA, supporting seamless integration in over 800 hospitals globally (Proximie Ltd - Digital Marketplace).

Regarding pricing, Proximie has a standard license fee of £16,800 per year, with no discounts for educational organizations and no free trial available (applytosupply.digitalmarketplace). Additionally, Proximi.io, another product, offers a tiered subscription model with a free basic package and paid plans that include advanced analytics and AI features, with pricing details available on their website (Proximi.io).

While specific recent pricing changes are not detailed, the platform's pricing structure emphasizes a combination of fixed annual licenses and customizable enterprise solutions, reflecting its focus on delivering measurable ROI through improved surgical workflows and training (Proximie Ltd - Digital Marketplace, Proxima).

Ad Campaigns

Proximie Ad Campaigns

Proximie is currently running 893 ads across Google, LinkedIn — 90 on Google and 803 on LinkedIn. Explore Proximie's live ad creative, messaging, and the platforms they advertise on in the ad library — updated automatically by ForesightIQ.

See of Proximie's ads

View ads

Hiring & Layoffs

Proximie Hiring and Layoffs

Proximie is experiencing rapid growth and actively expanding its workforce, with a reported 75% increase in employee numbers over the past 12 months, indicating a strong company strategy focused on scaling its healthcare technology solutions (Welcome to the Jungle). The company, founded in 2016 and based in Marylebone, London, specializes in virtual collaboration tools for clinicians, leveraging AI, augmented reality, and SaaS to transform surgical procedures and healthcare delivery (Welcome to the Jungle).

Proximie’s hiring trends show a focus on building a diverse and innovative team to support its mission of democratizing surgical skills and improving patient outcomes globally. The company’s growth is driven by increased demand for its platform, especially during the COVID-19 pandemic, which led to a 430% increase in usage and expanded access to over 90% of operating rooms and cath labs in the EU and US (Welcome to the Jungle).

While specific recent layoffs are not reported, the company's aggressive hiring and expansion into new markets suggest a strategic focus on innovation and market penetration rather than downsizing. This pattern signals a company committed to scaling its healthcare AI solutions and strengthening its position in the global medtech industry (Proximie Careers). Overall, Proximie’s hiring patterns reflect a forward-looking strategy aimed at leveraging technological advancements to revolutionize healthcare worldwide.

Leadership

Proximie Management and Leadership Team

Proximie is led by Nadine Hachach-Haram, who serves as the Founder and CEO of the company, bringing her extensive background as a practicing surgeon to the organization (Equilar). The leadership team also includes Richard Carter as the Chief Technology Officer, Charlie Robins as Vice President of Sales for the Americas, and Bryn Davies as the Chief People Officer, among others (The Org). Recent updates indicate that Prem Batchu-Green was appointed as the General Manager for the Americas in December 2025, and Jim Macdougall joined as Chief People Officer in June 2025 (Equilar).

The company's board includes an advisor, Scott Huennekens, though specific details about additional board members or recent leadership changes are limited in the available sources. Overall, Proximie continues to expand its leadership with notable hires at the executive level, emphasizing its growth in health technology and surgical collaboration (The Org).

Financials

Proximie Financial Performance, Fundraising, M&A

Proximie has demonstrated significant financial growth and activity in recent years. As of 2025, the company reported an annual revenue of approximately $12.5 million, with an estimated valuation of around $40 million, and it has not disclosed any recent funding rounds, indicating a potentially strong financial position without external funding (prospeo.io). Additionally, estimates from Growjo suggest that Proximie generates about $28.4 million annually, with a revenue per employee of $270,000, and has raised a total of $38 million in funding, primarily from institutional investors (growjo.com).

In terms of strategic activity, Proximie has been active in M&A and investments, with recent reports from 2021 indicating ongoing funding rounds and investor interest, although specific details on recent acquisitions or mergers are limited. The company's focus remains on expanding its platform capabilities in healthcare technology, particularly in surgical efficiency and remote collaboration, which supports its revenue growth and valuation (tracxn.com).

Overall, Proximie appears to be a financially healthy company with robust revenue figures, substantial valuation estimates, and active investment and growth strategies, positioning it as a notable player in healthcare technology and surgical innovation.

Partnerships

Proximie Partnerships, Clients and Vendors

Proximie has established significant partnerships and collaborations within the healthcare technology ecosystem, focusing on enhancing surgical and clinical practices through innovative digital solutions. In October 2024, Olympus Corporation announced a strategic partnership with Proximie to digitize operating rooms and facilitate real-time remote collaboration among clinicians, surgeons, and medical staff globally. This partnership aims to improve patient outcomes by enabling remote consultation, training, and sharing of clinical expertise through Proximie's cloud-based platform (Olympus America).

Proximie’s technology is also integrated with secure telehealth devices and supported by cloud platforms like HiveMQ, which standardizes communication protocols such as MQTT for reliable, mission-critical medical collaboration. This integration enhances the platform’s ability to operate across diverse infrastructure environments, promoting better patient outcomes and operational efficiency (hivemq.com).

Furthermore, Distalmotion, a pioneer in robotic surgery, partnered with Proximie in January 2024 to extend its Dexter® robotic surgery platform globally. This collaboration allows for seamless sharing of surgeon expertise and OR data, fostering greater collaboration and improving surgical care quality. The integration of Proximie’s platform with Distalmotion’s robotic systems exemplifies how Proximie’s ecosystem supports advanced surgical technologies and enhances clinical workflows (GlobeNewswire).

Events

Proximie Event Participations

Proximie actively participates in various industry events, including conferences, trade shows, webinars, and community events, to promote its innovative healthcare technology solutions. Notably, they are involved in the Healthcare Summit 2026, scheduled for September 22, 2026, at the Business Design Centre in London, where they likely showcase their digital operating room solutions and connect with healthcare professionals (Healthcare Summit).

While specific details about all their event participations are not exhaustively listed in the search results, it is clear that Proximie engages in prominent healthcare industry gatherings to demonstrate the value of digitizing operating rooms and to foster collaborations within the medical community (Healthcare Summit). Their involvement in such events underscores their commitment to advancing surgical technology and digital health innovations.

Frequently Asked Questions

What does Proximie's 75% headcount growth over 12 months signal about where they are in their scaling cycle?

Proximie's 75% year-over-year headcount increase — against a base of roughly 96 employees — signals a company in aggressive early-scale mode, not yet at enterprise maturity. The hires are concentrated at the leadership level (a new General Manager for the Americas appointed December 2025, a new Chief People Officer joining June 2025) alongside a VP of Sales for the Americas, which points to a deliberate push to build out a U.S. commercial motion rather than just deepening the existing UK base. No layoffs have been reported, reinforcing that the growth is demand-driven rather than a reset.

What does Proximie's appointment of a dedicated General Manager for the Americas in late 2025 reveal about their geographic strategy?

The December 2025 appointment of Prem Batchu-Green as General Manager for the Americas, layered on top of Charlie Robins as VP of Sales for the Americas, signals that Proximie is treating the U.S. market as a distinct, high-priority growth theater rather than an extension of its UK operation. This two-executive structure for a single region — one commercial, one general management — suggests they are moving from opportunistic U.S. sales toward a structured, locally accountable go-to-market organization. Given that the platform already claims coverage in over 90% of U.S. operating rooms and cath labs, the investment appears aimed at converting access into contracted recurring revenue.

Is Proximie's financial picture a growth story or a warning sign — and how reliable are the available numbers?

The financial picture is genuinely ambiguous and analysts should weight the numbers carefully. One source (Prospeo) estimates 2025 annual revenue at roughly $12.5 million with a $40 million valuation, while Growjo estimates $28.4 million in annual revenue and only $38 million raised in total funding — figures that conflict with the $118 million total funding cited in Proximie's own overview materials. The revenue-per-employee figure of $270,000 on a ~96-person headcount would imply the higher revenue estimate, but none of these are audited. What is clear is that Proximie has not disclosed a recent funding round, which either signals sufficient runway from prior raises or a deliberate move toward profitability — the data does not resolve which.

What does the Olympus partnership announced in October 2024 signal about Proximie's enterprise go-to-market evolution?

The Olympus partnership is the clearest signal that Proximie is pivoting toward a channel and co-sell model with major medtech OEMs rather than selling directly to hospitals alone. Olympus is one of the world's dominant endoscopy and surgical equipment suppliers, giving Proximie embedded distribution into OR procurement relationships that would take years to build independently. Combined with the earlier Distalmotion partnership (January 2024) integrating Proximie into a robotic surgery platform, the pattern suggests Proximie is deliberately positioning its platform as the connective tissue — the operating system layer — that OEM hardware vendors plug into, rather than competing device-by-device for hospital shelf space.

How does the Distalmotion partnership change the competitive calculus between Proximie and pure-play surgical robotics companies?

By integrating with Distalmotion's Dexter® robotic platform in January 2024, Proximie effectively neutralizes one axis of competitive threat from hardware-centric robotics companies: rather than being displaced by robotic systems, Proximie becomes the software layer that makes those systems more collaborative and data-rich. This positions Proximie as complementary to — rather than competing against — companies like Fundamental Surgery, which focuses on hardware-centric robotic-assisted procedures. The strategic implication is that Proximie is building an ecosystem lock-in: the more robotic and device OEMs integrate with its platform, the harder it becomes for hospitals to switch to an alternative OR operating system.

What does Proximie's £16,800 per-year standard license fee tell us about their target customer and deal velocity?

At £16,800 annually per site, Proximie's standard license is priced squarely at departmental or single-hospital budget authority — low enough to avoid a lengthy capital committee process in most NHS or mid-tier U.S. health system contexts, but meaningful enough to generate recurring SaaS revenue at scale. The absence of a free trial and no educational discounts suggests Proximie is not trying to build a bottoms-up adoption funnel through training programs; they are selling to procurement decision-makers who can commit budget. The listed price is likely a floor — the enterprise and device-company contracts with clients like Johnson & Johnson and Medtronic are almost certainly structured differently.

With two Chief People Officers in 2025 — Jim Macdougall joining in June and Bryn Davies listed as CPO — what does the leadership churn in the people function signal?

The presence of both Bryn Davies (listed as CPO) and Jim Macdougall (listed as joining as CPO in June 2025) in the available data suggests a leadership transition in the people function mid-year — likely Davies departing as Macdougall came on board. A CPO change during a period of 75% headcount growth is worth monitoring: rapid scaling while simultaneously resetting the HR leadership can create execution risk in recruiting, culture retention, and compensation structure. It may also reflect a deliberate upgrade — bringing in a more experienced people leader to manage the complexity of a rapidly internationalizing workforce.

What does Proximie's competitive positioning against Augmedics and Osso VR reveal about the segment it actually owns?

Compared to Augmedics (AR-guided navigation for spine surgery) and Osso VR (VR simulation for training), Proximie occupies a distinct and broader layer: real-time OR connectivity, data integration, and cross-institutional collaboration rather than single-procedure visualization or offline simulation. This means Proximie's competitive moat is horizontal — value comes from being embedded across an entire hospital's surgical workflow — while its named competitors are vertical specialists. The risk is that vertical specialists are harder to displace within their niche, but Proximie's platform approach gives it more total addressable market and makes it more attractive as an acquisition target for a large medtech or health IT player seeking OR software infrastructure.

What does Proximie's participation in the Healthcare Summit 2026 (London, September 2026) suggest about where they are focusing their business development energy in Europe?

Proximie's presence at the Healthcare Summit 2026 at the Business Design Centre in London — where they are contributing content on the value of digitizing operating rooms — signals that they are using the UK and European market as a thought leadership platform, not just a sales territory. Framing the message around 'surgeons calling for technology to be implemented' suggests the go-to-market narrative is clinician-pull rather than top-down procurement push, which aligns with founder-CEO Nadine Hachach-Haram's identity as a practicing surgeon. This approach is consistent with building trust in a risk-averse NHS and European hospital buying environment.

Does Proximie's total funding figure — with estimates ranging from $38 million to $118 million — affect how a corp-dev team should frame an acquisition or partnership valuation?

Yes, the funding discrepancy is material for corp-dev purposes. A $38 million total raised against a $40 million estimated valuation would imply near-zero equity appreciation for investors and create a cleaner acquisition conversation; $118 million raised against the same valuation would mean significant capital destruction and a more complex cap table negotiation. A strategy or M&A team should treat Proximie's own $118 million figure as the working assumption — it appears in company-controlled materials — while stress-testing whether the Growjo $38 million figure reflects an earlier data snapshot. Resolving this discrepancy is a prerequisite for any serious valuation work.

What does Proximie's platform architecture — integrating HiveMQ's MQTT protocol for device communication — signal about their enterprise infrastructure ambitions?

Proximie's use of HiveMQ as a standardized MQTT messaging layer for device communication signals that the company is engineering for mission-critical, high-reliability infrastructure rather than consumer-grade video collaboration. MQTT is the protocol of choice for IoT environments where connection reliability and low latency are non-negotiable — which is exactly the standard required for live surgical guidance. This architectural choice, combined with GDPR and HIPAA certifications and deployment in 800-plus hospitals, indicates that Proximie is positioning its platform as enterprise IT infrastructure, not a point solution — which raises both the integration complexity and the switching cost for any hospital that adopts it at scale.

Powered by ForesightIQ · Competitive intelligence from digital exhaust